BUYOUT OF THERAGENICS - LAW FIRM SEEKS HIGHER PRICE FOR SHAREHOLDERS
AUGUST 5, 2013
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, is investigating the Board of Directors of Theragenics Corporation (“Theragenics” or the “Company”) (TGX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Juniper Investment Company, LLC.
Under the terms of the transaction, Theragenics shareholders will receive $2.20 for each share of Theragenics stock they own. The investigation concerns whether the Theragenics Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Juniper Investment Company, LLC is underpaying for Theragenics shares. In particular, Theragenics has a reported book value of $2.64 for the most recent quarter.
If you own common stock in Theragenics and would like to participate with other shareholders who are seeking a higher price at no cost or expense please contact us at 1-877-772-3975 or email at contact @ tripplevy